142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

315941
Raced Narratives of Trust and Vaccination: Polio and the Tuskegee Syphilis Study

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 8:30 AM - 8:42 AM

Sandra Quinn, PhD , Department of Family Services, Maryland Center for Health Equity - School of Public Health University of Maryland, College Park, MD
Leah Curran, PhD , Center for Health Equity, University of Maryland School of Public Health, College Park, MD

Learning Areas:

Advocacy for health and health education
Diversity and culture
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Protection of the public in relation to communicable diseases including prevention or control
Provision of health care to the public

Learning Objectives:
Demonstrate the ability to comprehend the disparity among African American and Whites as it relates to the lack of immunizations for minorities. In this session, we will explore vaccine disparities and communication inequalities in the context of Public Health Critical Race Praxis.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Dr. Quinn is the Senior Associate Director of the Center for Health Equity at the School of Public Health, University of Maryland. She is the Principal Investigator (with Dr. Thomas) on the Center of Excellence in Race, Ethnicity and Health Disparities Research, funded by the National Institute for Minority Health and Health Disparities (NIMHD), and within it, she is also the Principal Investigator on a study, Uncovering and Addressing Cultural Beliefs behind Vaccine Racial Disparities.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.